{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T10:17:19Z","timestamp":1648808239701},"reference-count":22,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Archives de P\u00e9diatrie"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.arcped.2011.08.024","type":"journal-article","created":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T19:11:33Z","timestamp":1317496293000},"page":"1218-1223","source":"Crossref","is-referenced-by-count":0,"title":["Nouveaux traitements en rhumatologie p\u00e9diatrique\u00a0: impact, limites et perspectives"],"prefix":"10.1016","volume":"18","author":[{"given":"P.","family":"Quartier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcped.2011.08.024_bib0005","first-page":"390","article-title":"International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision. Edmonton, 2001","volume":"31","author":"Petty","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.arcped.2011.08.024_bib0010","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jbspin.2008.10.015","article-title":"Ocular threat in juvenile idiopathic arthritis","volume":"76","author":"Marvillet","year":"2009","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.arcped.2011.08.024_bib0015","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.arcped.2010.04.001","article-title":"Recommandations pour la prise en charge de la forme syst\u00e9mique l\u2019arthrite juv\u00e9nile idiopathique (maladie de Still)","volume":"17","author":"Bader-Meunier","year":"2010","journal-title":"Arch Pediatr"},{"key":"10.1016\/j.arcped.2011.08.024_bib0020","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.arcped.2010.04.002","article-title":"Recommandations pour la prise en charge des formes oligoarticulaire et polyarticulaires (en dehors de la polyarthrite rhumato\u00efde) d\u2019arthrite juv\u00e9nile idiopathique","volume":"17","author":"Bader-Meunier","year":"2010","journal-title":"Arch Pediatr"},{"key":"10.1016\/j.arcped.2011.08.024_bib0025","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/j.arcped.2009.07.020","article-title":"Nouveaux traitements de l\u2019arthrite juv\u00e9nile idiopathique","volume":"16","author":"Bader-Meunier","year":"2009","journal-title":"Arch Pediatr"},{"key":"10.1016\/j.arcped.2011.08.024_bib0030","first-page":"624","article-title":"Anakinra treatment prior to steroids in newly diagnosed systemic onset JIA: changing the biology?","volume":"69","author":"De Jager","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.arcped.2011.08.024_bib0035","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0929-693X(09)74053-9","article-title":"Prise en charge diagnostique et th\u00e9rapeutique des uv\u00e9ites de l\u2019enfant","volume":"16","author":"Bodaghi","year":"2009","journal-title":"Arch Pediatr"},{"key":"10.1016\/j.arcped.2011.08.024_bib0040","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1056\/NEJMoa041810","article-title":"Leflunomide in Juvenile Rheumatoid Arthritis (JRA) Investigator Group. Leflunomide or methotrexate for juvenile rheumatoid arthritis","volume":"352","author":"Silverman","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arcped.2011.08.024_bib0045","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1002\/art.10885","article-title":"Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type","volume":"48","author":"Quartier","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.arcped.2011.08.024_bib0050","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1093\/rheumatology\/keq136","article-title":"Occurrence of inflammatory bowel disease during treatment of juvenile idiopathic arthritis with etanercept: a French retrospective study","volume":"49","author":"Dallocchio","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.arcped.2011.08.024_bib0055","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1056\/NEJM200003163421103","article-title":"Etanercept in children with polyarticular juvenile rheumatoid arthritis","volume":"342","author":"Lovell","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arcped.2011.08.024_bib0060","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.1002\/art.22838","article-title":"A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis","volume":"56","author":"Ruperto","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.arcped.2011.08.024_bib0065","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1056\/NEJMoa0706290","article-title":"Adalimumab with or without methotrexate in juvenile rheumatoid arthritis","volume":"359","author":"Lovell","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arcped.2011.08.024_bib0070","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0140-6736(08)60998-8","article-title":"Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial","volume":"372","author":"Ruperto","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.arcped.2011.08.024_bib0075","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1002\/art.27431","article-title":"Long-term safety and efficacy of abatacept in children with juvenile idiopathic arthritis","volume":"62","author":"Ruperto","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.arcped.2011.08.024_bib0080","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0140-6736(08)60454-7","article-title":"Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial","volume":"371","author":"Yokota","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.arcped.2011.08.024_bib0085","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/art.25057","article-title":"Long-term efficacy of the interleukin-1\u00a0receptor antagonist anakinra in ten patients with neonatal-onset multisystem inflammatory disease\/chronic infantile neurologic, cutaneous, articular syndrome","volume":"62","author":"Neven","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.arcped.2011.08.024_bib0090","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/art.30105","article-title":"The emerging role of interleukin-1\u03b2 in autoinflammatory diseases","volume":"63","author":"Lachmann","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.arcped.2011.08.024_bib0095","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1136\/ard.2010.134254","article-title":"A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1\u00a0receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)","volume":"70","author":"Quartier","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.arcped.2011.08.024_bib0100","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1001\/jama.2010.375","article-title":"Methotrexate withdrawal at 6\u00a0vs. 12\u00a0months in juvenile idiopathic arthritis in remission: a randomized clinical trial","volume":"303","author":"Foell","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.arcped.2011.08.024_bib0105","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1210\/jc.2006-2877","article-title":"Early recombinant human growth hormone treatment in glucocorticoid-treated children with juvenile idiopathic arthritis: a 3-year randomized study","volume":"92","author":"Simon","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcped.2011.08.024_bib0110","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1002\/art.27741","article-title":"Juvenile idiopathic arthritis and risk of cancer: a nationwide study","volume":"62","author":"Simard","year":"2010","journal-title":"Arthritis Rheum"}],"container-title":["Archives de P\u00e9diatrie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929693X11003769?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929693X11003769?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T13:55:44Z","timestamp":1543499744000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929693X11003769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":22,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0929693X11003769"],"URL":"https:\/\/doi.org\/10.1016\/j.arcped.2011.08.024","relation":{},"ISSN":["0929-693X"],"issn-type":[{"value":"0929-693X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}